Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
作者： Wei Han , Huili Lu
DOI:
关键词:
摘要: CXCL9 promotes bone marrow regeneration, increases peripheral white blood cells, and survival if administered prior to treatment of a subject with chemotherapeutic drugs such as 5-FU or radiotherapy. Similar effects are obtained by administering an anti-CXCL9 antibody following chemotherapy Compositions methods presented for the cancer diseases.
lens.org参考文章(93)
J. Michael Ruehlmann, Stephen D. Gillies, Andreas G. Niethammer, Carrie S. Dolman, Ursula Pertl, Rong Xiang, Ralph A. Reisfeld, Yi Ba, MIG (CXCL9) Chemokine Gene Therapy Combines with Antibody-Cytokine Fusion Protein to Suppress Growth and Dissemination of Murine Colon Carcinoma Cancer Research. ,vol. 61, pp. 8498- 8503 ,(2001)
Gopinadhan N. Anilkumar, Lisa Guise Zawacki, Guizhen Dong, Qingbei Zeng, Neng-Yang Shih, Yuefei Shao, Michael K.C. Wong, Stuart B. Rosenblum, John J. Baldwin, Wensheng Yu, Bandarpalle B. Shankar, Douglas W. Hobbs, Yueheng Jiang, Brian F. Mcguinness, Joseph A. Kozlowski, Seong Heon Kim, Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity ,(2006)
Ning Zhu, Robert James Debs, Methods and compositions for in vivo gene therapy ,(1993)
Kenneth L. Brigham, Method of in vivo delivery of functioning foreign genes ,(1990)
Gopinadhan N. Anilkumar, Qingbei Zeng, Brian F. McGuinness, Yuefei Shao, Michael K. C. Wong, Stuart B. Rosenblum, Douglas W. Hobbs, Joseph A. Kozlowski, Seong Heon Kim, Heterocyclic substituted piperazines with cxcr3 antagonist activity ,(2006)
L. G. Davis, W. M. Kuehl, J. F. Battey, Basic methods in molecular biology ,(1986)
Hiromu Habashita, Shiro Shibayama, Spiropiperidine compound and medicinal use thereof ,(2006)
Lyman G. Armes, Tadahiko Kohno, Robert C. Thompson, Ronald J. Evans, Michael T. Brewer, Pegylation of polypeptides ,(1992)
Keelung Hong, Demetrios Papahadjopoulos, Weiwen Zheng, Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery ,(1997)
David T. Scadden, Mark C. Poznansky, Andrew D. Luster, Purposeful movement of human migratory cells away from an agent source ,(2000)